R. Herrmann
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- Pancreatic and Hepatic Oncology Research
- Hematology top 10%
- Erythropoietin and Anemia Treatment
Papers in
- Oncology 21
- Colorectal Cancer Treatments and Studies 11
- Lung Cancer Research Studies 3
-
- Gastric Cancer Management and Outcomes 12
- Lung Cancer Treatments and Mutations 7
- Co-authors
- Helmut R. Maëcke (2 shared papers)Andreas Otte (2 shared papers)Martin Béhé (1 shared paper)A. Heppeler (1 shared paper)Bengt Glimelius (2 shared papers)Markus Borner (5 shared papers)A. Roth (3 shared papers)Hanspeter Honegger (3 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)European Journal of Cancer (6 papers)Recent results in cancer research (2 papers)Annals of Oncology (2 papers)Acta Oncologica (1 paper)
- Partner nations
- SwitzerlandGermanyItaly
In The Last Decade
R. Herrmann
39 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 80
- Oncology 504
- Hematology 121
- Pulmonary and Respiratory Medicine 298
- Neurology 125
- Epidemiology 232
Countries citing papers authored by R. Herrmann
This map shows the geographic impact of R. Herrmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Herrmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Herrmann more than expected).
Fields of papers citing papers by R. Herrmann
This network shows the impact of papers produced by R. Herrmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Herrmann. The network helps show where R. Herrmann may publish in the future.
Co-authors
The 25 scholars most cited alongside R. Herrmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 269 | |
| 2 | 2000 | 174 | |
| 3 | Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer | 1994 | 162 |
| 4 | 1998 | 89 | |
| 5 | 2005 | 55 | |
| 6 | 2004 | 40 | |
| 7 | 1973 | 26 | |
| 8 | 2001 | 26 | |
| 9 | 2000 | 26 | |
| 10 | 1987 | 25 | |
| 11 | 2006 | 25 | |
| 12 | 1993 | 21 | |
| 13 | 1998 | 21 | |
| 14 | 1993 | 19 | |
| 15 | 1988 | 17 | |
| 16 | 2008 | 15 | |
| 17 | [Yttrium 90 DOTATOC: a new somatostatin analog for cancer therapy of neuroendocrine tumors]. | 1999 | 13 |
| 18 | 2003 | 12 | |
| 19 | New aspects in the treatment of advanced low-grade non-Hodgkin's lymphomas: prednimustine/mitoxantrone versus cyclophosphamide/vincristine/prednisone followed by interferon alfa versus observation only--a preliminary update of the German Low-Grade Lymphoma Study Group. | 1994 | 10 |
| 20 | 2011 | 9 |
About R. Herrmann
R. Herrmann is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Pathology and Forensic Medicine and Hematology, having authored 45 papers that have together received 1.1k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (12 papers), Colorectal Cancer Treatments and Studies (11 papers), Lung Cancer Treatments and Mutations (7 papers), Congenital Anomalies and Fetal Surgery (5 papers), Esophageal Cancer Research and Treatment (5 papers), Lymphoma Diagnosis and Treatment (4 papers), Animal health and immunology (3 papers) and Lung Cancer Research Studies (3 papers). The work is most often cited by research in Oncology (504 citations), Hematology (121 citations), Pulmonary and Respiratory Medicine (298 citations), Neurology (125 citations) and Epidemiology (232 citations). R. Herrmann has collaborated with scholars based in Switzerland, Germany and Italy. Frequent co-authors include Helmut R. Maëcke, Andreas Otte, Martin Béhé, A. Heppeler, Bengt Glimelius, Markus Borner, A. Roth, Hanspeter Honegger, Marc Buyse and Albert Abad. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Recent results in cancer research, Annals of Oncology and Acta Oncologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.